Browsing Tag
Kyowa Kirin Co.
1 post
Why did Amgen Inc. walk away from its $1.25bn eczema drug deal with Kyowa Kirin?
Amgen Inc. exits its $1.25B eczema drug deal with Kyowa Kirin Co., Ltd., reshaping its immunology focus. Find out what this move means for both companies’ pipelines.